Regeneron Pharmaceuticals
REGN
#190
Rank
NZ$150.82 B
Marketcap
$1,373
Share price
0.96%
Change (1 day)
-1.93%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $60.54

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $62.19. In 2022 the company made an earnings per share (EPS) of $67.45 a decrease over its 2021 EPS that were of $127.27.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$60.54-10.25%
2022$67.45-47%
2021$127.27133.36%
2020$54.5469.13%
2019$32.25-14.44%
2018$37.69100.71%
2017$18.7831.78%
2016$14.2538.96%
2015$10.2572.55%
2014$5.94-17.55%
2013$7.21-44.98%
2012$13.10-422.54%
2011-$4.0692.13%
2010-$2.1149.41%
2009-$1.41-15.84%
2008-$1.68-36.88%
2007-$2.66-9.6%
2006-$2.954.12%
2005-$2.83-323.68%
2004$1.27-135.51%
2003-$3.56-24.38%
2002-$4.7156.35%
2001-$3.01187.3%
2000-$1.05-16%
1999-$1.25177.78%
1998-$0.45-35.71%
1997-$0.70-68.42%
1996-$2.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.56-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.84-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.73-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$23.45-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.23-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.29-91.49%๐Ÿ‡ซ๐Ÿ‡ท France